IRIS
MILANESE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.389
AS - Asia 1.339
SA - Sud America 168
NA - Nord America 144
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.064
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.358
SG - Singapore 560
CN - Cina 384
VN - Vietnam 285
BR - Brasile 102
US - Stati Uniti d'America 101
HK - Hong Kong 56
AR - Argentina 38
MX - Messico 34
ID - Indonesia 18
RU - Federazione Russa 9
CO - Colombia 7
IQ - Iraq 7
ZA - Sudafrica 7
GB - Regno Unito 6
IN - India 6
VE - Venezuela 6
CA - Canada 5
EC - Ecuador 5
JP - Giappone 5
BD - Bangladesh 4
PY - Paraguay 4
SE - Svezia 4
PL - Polonia 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
MA - Marocco 2
PK - Pakistan 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DE - Germania 1
EG - Egitto 1
ES - Italia 1
GY - Guiana 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NL - Olanda 1
RO - Romania 1
TL - Timor Orientale 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
YT - Mayotte 1
Totale 21.064
Salva come PNG Salva come JPEG
Città #
Genova 9.343
Genoa 6.771
Vado Ligure 1.683
Rapallo 1.492
Singapore 206
Beijing 106
Ho Chi Minh City 99
Hanoi 61
Hong Kong 56
Ashburn 46
Bordighera 40
Mexico City 23
Haiphong 16
Da Nang 15
Tianjin 15
São Paulo 13
Biên Hòa 11
New York 9
Milan 8
Los Angeles 7
Staten Island 7
Denton 6
Hải Dương 6
Quảng Ngãi 6
Bắc Ninh 5
Can Tho 5
Phủ Lý 5
Thái Bình 5
Tokyo 5
Turin 5
Baghdad 4
Buenos Aires 4
Council Bluffs 4
Montreal 4
Orem 4
Shijiazhuang 4
Chicago 3
Curitiba 3
Dakar 3
Guangzhou 3
Makhachkala 3
Phú Thọ 3
Quito 3
Rio de Janeiro 3
Rome 3
Stockholm 3
Wuhan 3
Zhengzhou 3
Asunción 2
Bandung 2
Basingstoke 2
Braga 2
Bình Dương 2
Cape Town 2
Changsha 2
Chongqing 2
Córdoba 2
Denver 2
Goiânia 2
Guayaquil 2
Hangzhou 2
Hortolândia 2
Jakarta 2
Johannesburg 2
La Plata 2
La Spezia 2
Luoyang 2
Nam Định 2
Nha Trang 2
Poplar 2
Querétaro 2
Quận Chín 2
Rafael Castillo 2
San José 2
Sydney 2
Sóc Trăng 2
Teresópolis 2
Tuxtla Gutiérrez 2
Verona 2
Vinh 2
Wroclaw 2
Abu Dhabi 1
Ajman 1
Aksay 1
Al Kazimiyah 1
Alagoinhas 1
Alegre 1
Algiers 1
Amman 1
Amparo 1
Amsterdam 1
Angra dos Reis 1
Ankara 1
Apodaca 1
Arroyo Seco 1
Artur Nogueira 1
As Sālimīyah 1
Atlanta 1
Augusta 1
Bagé 1
Totale 20.220
Salva come PNG Salva come JPEG
Nome #
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 218
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 205
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 204
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 203
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 197
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 192
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 191
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 184
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 179
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 175
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 169
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 167
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 158
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 158
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 157
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 155
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 154
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 153
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 152
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 149
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 149
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 149
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 147
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 147
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 146
Metabotropic glutamate receptor 5 as a potential target in ALS 146
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 145
Synthesis and evaluation of resins bearing substrate-like inhibitor functions for capturing copper amine oxidases 145
A New Function for Glycine GLYT2 Transporters: Stimulation of GABA Release from Cerebellar Nerve Terminals Through GAT-1 Transporter Reversal and Ca2+-Dependent Anion Channels 143
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 143
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 143
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 143
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 142
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 140
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 139
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 138
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 135
Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice 134
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 133
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 133
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 130
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 130
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization 129
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 129
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 128
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 127
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 127
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 127
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 126
Role of calpain-1 in the early phase of experimental ALS 126
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 126
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 125
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 124
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 124
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 124
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 123
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 123
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 122
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 122
Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C properties 121
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 121
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 120
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice 119
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 119
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of wobbler mice, a model of motor neuron disease. 117
The GABAergic-like system in the cyprid of Balanus amphitrite (=Amphibalanus amphitrite) (Cirripedia, Crustacea) 117
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 117
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 117
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 117
Cognitive impairment in Gdi1 deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training 117
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 115
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 115
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 114
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS. 114
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 114
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 113
Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synapticplasticity, and visual functions in a mouse model of Down syndrome 113
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 112
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 110
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis 109
Proteomic analysis of gliosomes from mouse brain: identification and investigation of glial membrane proteins 109
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 109
Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress 109
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 109
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 109
Targeting group i metabotropic glutamate receptors in experimental als. 109
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 108
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through corticosterone non-genomic action 108
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism 108
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury 107
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 107
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 107
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 106
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 106
Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia 106
In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOd1/G93A(+) mouse model of amyotrophioc lateral sclerosis. 106
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 105
Knocking-down Group I metabotropic glutamate receptors ameliorates survival and disease progression in SOD1G93A mice. 105
Group I metabotropic glutamate receptors modulate glutamate exocytosis in a mouse model of als 105
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 105
Totale 13.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.242
article - articoli 34.866
book - libri 999
conference - conferenze 36.377
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021664 0 0 0 0 0 79 85 117 95 109 82 97
2021/20221.900 37 119 108 191 79 148 123 470 107 173 69 276
2022/20231.838 187 169 23 206 274 289 12 116 295 14 212 41
2023/20241.510 50 175 49 178 124 302 119 67 65 70 108 203
2024/20254.530 218 307 124 307 501 425 384 803 131 200 522 608
2025/20263.970 1.033 242 547 662 1.352 134 0 0 0 0 0 0
Totale 21.685